LYCEUM-NORTHWESTERN UNIVERSITY

COLLEGE OF NURSING

Related Learning Experience Plan

1st Semester 2020-2021

Course Title: NCM 109- Care of Mother, Child at Risk or with Problems (Acute &
Chronic)
NURSING CARE PLAN
Assessment Planning Implementation Rationale Evaluation
Nursing Problem: Short-term Independent  Provides  Responses
Risk for deficient Goal: Nursing information about to
fluid volume  Patient will Intervention: active bleeding interventions,
be able to  Assess versus old blood, teachings
express her hourly intake and tissue loss and and actions
Data: emotions output. degree of blood performed.
from the  Assess baseline loss.  Attainment
Subjective second time data and note  Assessment and progress
No uterine activity uneventful. changes. provides toward
The patient  Monitor fetal information about desired
verbalizes Long-term heart rate. possible infection, outcome.
“Awakened at 2:00 Goal: placenta previa or Modifications to
am and she had wet  Patient will abruption. Warm, plan of care.
the bed” maintain Dependent moist, bloody
“She discovered her fluid volume Nursing environment is
bed was covered in at a Intervention: ideal for growth of
bright red blood” functional  Initiate IV microorganisms.
Woman experiences level fluids as
painless bleeding possibly ordered  For replacement
evidenced (specify fluid of fluid vol. loss.
Objective by adequate type and
26 y/o G2P1 (2004) urinary rate).  Lab Work
37 WOG output and provides
Vital Signs stable vital Collaborative information
T 98.6 F, P 84, R signs. Management: about degree
20, BP 126/74  Monitor lab. of blood loss;
Work as prepares for
Nursing obtained: possible
Diagnosis: Hgb & Hct, transfusion.
 Deficient Rh and type, Ultrasound
Fluid cross match provides info
Volume r/t for 2 units about the
Active Blood RBCs, cause of
Loss urinalysis, bleeding
Secondary to etc.
Disrupted Scheduled
Placental for ultrasound
Implantation as ordered.
 LYCEUM-NORTHWESTERN UNIVERSITY
COLLEGE OF NURSING

DRUG STUDY

Name of the Classification Indications Side Effects Nursing Implications

drug Pharmacologic: General:
CNS: CNS Before:
Ferrous Iron Preparation  Prevention and toxicity,  Check the doctor’s
Sulfate treatment of acidosis, order.
Therapeutic: iron deficiency coma, and  Assess for allergy to
Ferrous Iron Preparation anemias. death with any ingredient,
sulfate (or sulp  Dietary overdose sulfite,
hate) is a Pregnancy supplement for hemochromatosis,
medicine used  Category Risk: iron GI: GI upset, hemosiderosis,
to treat and A  Unlabeled use: anorexia, haemolytic anemias
prevent iron supplemental nausea,  Assess for skin
deficiency use during vomiting, lesions, color;
anaemia. Iron epoetin therapy constipation, gums, teeth (color);
helps the body to ensure diarrhea, dark bowel sounds
to make proper stools,  Monitor blood loss
healthy red hematologic temporary  Confirm that client
blood cells, response to staining of does have iron
which carry epoietin teeth (liquid deficiency anemia
oxygen around preparations)
the body. Patients actual During:
Some things indication:  Verify patient’s identity
such as blood Ferrous sulfate is  Administer the right
loss, given to the patient drug in the right dose
pregnancy or for the prevention and route at the right
too little iron in and treatment of time
your diet can iron-deficiency  Do not crush, chew, or
make your iron anemia brought cut tablets and
supply drop about by the capsules
too low, illness.  Give drug with meals
leading to (avoiding milk, eggs,
anaemia. coffee, and tea)
 Administer liquid
preparations in water or
juice to mask the taste
and prevent staining of
teeth; have patient
drink solution with a
 straw
 Do not take this drug
with antacids nor
tetracyclines unless
prescribed
Generic Mechanism of Contraindications Adverse
Name: Action: : Effects After:
Ferrous Elevates the Contraindicated  Warn patient that stool
Sulfate serum iron with allergy to any Nausea, may be dark or green
concentration and ingredient; sulphite epigastric  Arrange for periodic
Brand Name: is then converted energy; discomfort, monitoring of hct and
Femiron, hgb or trapped in hemochromatosis, abdominal hgb levels
Hemocyte, the haemolytic cramps,  Keep this drug out of
Ircon retinoendothelial anemias constipation reach of children (may
cells for storage and diarrhea. cause poisoning)
and eventual  Report severe GI
conversion to a Precaution: upset, lethargy, rapid
Dosage: usable form of Use cautiously respirations, and
1-tab TID iron. with normal iron constipation
8mg/day- balance; peptic  Document and record.
350mg/day Onset: ulcer, regional
4 days enteritis, ulcerative
colitis
Peak:
7-10 days

Metabolism:
Recycled for use,
not known

Distribution:
Crosses
placenta, enters
breast milk

Excretion:
Unknown